Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroyuki Osada

Showing results (21-30 of 476) with videos related to

Pageof 48
Sort By:
Bioorganic & Medicinal Chemistry Letters|November 21, 2016
Biosynthetic approaches to creating bioactive fungal metabolites: Pathway engineering and activation of secondary metabolismTakayuki Motoyama, Hiroyuki Osada
Cancer Science|August 14, 2009
Osteoclast-targeting small molecules for the treatment of neoplastic bone metastasesMakoto Kawatani, Hiroyuki Osada
The Journal of Antibiotics|July 20, 2021
Proteomics-based target identification of natural products affecting cancer metabolismMakoto Muroi, Hiroyuki Osada
Methods in Enzymology|October 11, 2022
Two-dimensional electrophoresis-cellular thermal shift assay (2DE-CETSA) for target identification of bioactive compoundsMakoto Muroi, Hiroyuki Osada
Bioscience, Biotechnology, and Biochemistry|September 8, 2011
Actin stress fiber retraction and aggresome formation is a common cellular response to actin toxinsSayaka Kazami, Takeo Usui, Hiroyuki Osada
FEBS Letters|July 1, 2004
The phosphorylation status and anti-apoptotic activity of Bcl-2 are regulated by ERK and protein phosphatase 2A on the mitochondriaYuki Tamura, Siro Simizu, Hiroyuki Osada
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 31, 2004
[Mode of action and molecular target of ECH, a specific inhibitor of death receptor-dependent apoptosis]Yasunobu Miyake, Hideaki Kakeya, Hiroyuki Osada
Methods in Molecular Biology (Clifton, N.J.)|September 22, 2010
The application of the chemical array for biological studyIsao Miyazaki, Siro Simizu, Hiroyuki Osada
Cancer Science|July 13, 2004
Heparanase as a molecular target of cancer chemotherapySiro Simizu, Keisuke Ishida, Hiroyuki Osada
The Journal of Biological Chemistry|June 14, 2002
A novel adenine nucleotide translocase inhibitor, MT-21, induces cytochrome c release by a mitochondrial permeability transition-independent mechanismKiyotaka Machida, Yujiro Hayashi, Hiroyuki Osada
Pageof 48

Showing results (21-30 of 476) with videos related to

Sort By:
Pageof 48
Bioorganic & Medicinal Chemistry Letters|November 21, 2016
Biosynthetic approaches to creating bioactive fungal metabolites: Pathway engineering and activation of secondary metabolismTakayuki Motoyama, Hiroyuki Osada
Cancer Science|August 14, 2009
Osteoclast-targeting small molecules for the treatment of neoplastic bone metastasesMakoto Kawatani, Hiroyuki Osada
The Journal of Antibiotics|July 20, 2021
Proteomics-based target identification of natural products affecting cancer metabolismMakoto Muroi, Hiroyuki Osada
Methods in Enzymology|October 11, 2022
Two-dimensional electrophoresis-cellular thermal shift assay (2DE-CETSA) for target identification of bioactive compoundsMakoto Muroi, Hiroyuki Osada
Bioscience, Biotechnology, and Biochemistry|September 8, 2011
Actin stress fiber retraction and aggresome formation is a common cellular response to actin toxinsSayaka Kazami, Takeo Usui, Hiroyuki Osada
FEBS Letters|July 1, 2004
The phosphorylation status and anti-apoptotic activity of Bcl-2 are regulated by ERK and protein phosphatase 2A on the mitochondriaYuki Tamura, Siro Simizu, Hiroyuki Osada
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 31, 2004
[Mode of action and molecular target of ECH, a specific inhibitor of death receptor-dependent apoptosis]Yasunobu Miyake, Hideaki Kakeya, Hiroyuki Osada
Methods in Molecular Biology (Clifton, N.J.)|September 22, 2010
The application of the chemical array for biological studyIsao Miyazaki, Siro Simizu, Hiroyuki Osada
Cancer Science|July 13, 2004
Heparanase as a molecular target of cancer chemotherapySiro Simizu, Keisuke Ishida, Hiroyuki Osada
The Journal of Biological Chemistry|June 14, 2002
A novel adenine nucleotide translocase inhibitor, MT-21, induces cytochrome c release by a mitochondrial permeability transition-independent mechanismKiyotaka Machida, Yujiro Hayashi, Hiroyuki Osada
Pageof 48